Vinayak Doraiswamy

Chief Scientific Officer

Vinayak Doraiswamy (Chief Scientific Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in AtriCure, Inc. (ATRC). The largest single filing was $233K of ATRC (6,000 sh × $38.88, as filed), executed Jul 28.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$523K

shares × price, as filed

Last traded

Jul 28

Filed Jul 30

Median ADV $43.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $523K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

ATRC

AtriCure, Inc. ATRC · 0 buys · 3 sells 3 filings

Recent filings

ATRCSALE AtriCure, Inc. View filing → $233K
6,000 sh × $38.88
Exec Jul 28
Filed Jul 30 · 4:57 PM ET ATRCSALE AtriCure, Inc. View filing → $141K
5,000 sh × $28.13
Exec May 15
Filed May 18 · 5:30 PM ET ATRCSALE AtriCure, Inc. View filing → $149K
5,000 sh × $29.83
Exec Mar 12
Filed Mar 16 · 5:30 PM ET